Teva Pharmaceuticals USA Inc.

Statement of Charges and Notice of Hearing regarding the "false and misleading marketing" of opiod products in the matter of Teva Pharmaceutical Industries Ltd., of Israel; Teva Pharmaceuticals USA Inc., of Pennsylvania; Cephalon Inc., of Delaware; Watson Laboratories Inc., of Nevada; Actavis Pharma Inc., of Delaware; Actavis LLC, of Delaware; Actavis Elizabeth LLC, of Delaware; Allergan Plc, of Ireland, and Allergan Finance LLC, of Nevada, before the New York State Department of Financial Services.

Complaint in Migdal Mutual Funds Ltd., of Israel v. Teva Pharmaceutical Industries Ltd., of Israel; Teva Pharmaceuticals USA Inc., of Pennsylvania; Eerez Vigodman, Eyal Desheh, Allan Oberman, Sigurdur Olafsson, Deborah Griffin, Yaacov Altman, Yitzhak Peterburg, Dipankar Bhattacharjee, Michael McClellan, Kare Schultz, and Maureen Cavanaugh at the U. S. District Court for the District of Connecticut.